|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.02 CAD | -42.86% |
|
-42.86% | -63.64% |
Quest PharmaTech Inc. reported earnings results for the full year ended January 31, 2023. For the full year, the company reported net loss was CAD 7.33 million compared to CAD 85.04 million a year ago. Basic loss per share from continuing operations was CAD 0.043 compared to CAD 0.505 a year ago.
Diluted loss per share from continuing operations was CAD 0.043 compared to CAD 0.505 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -63.64% | 2.47M | |
| +1.51% | 42.75B | |
| +48.32% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
QUEST PHARMATECH INC. 
